Sinopharm Group Forecast, price target & analysts
Sinopharm Group Target price 2026 - Analyst rating & recommendation
Sinopharm Group Classifications & Recommendation
Sinopharm Group Price Target
| Target Price | HK$21.52 |
| Price | HK$14.91 |
| Potential |
44.35%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target Sinopharm Group 2027 .
The average Sinopharm Group target price is HK$21.52.
This is
44.35%
register free of charge
HK$28.32
89.93%
register free of charge
HK$17.17
15.16%
register free of charge
|
|
| A rating was issued by 21 analysts: 15 Analysts recommend Sinopharm Group to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sinopharm Group stock has an average upside potential 2027 of
44.35%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 672.04 | 696.33 |
| 1.60% | 3.61% | |
| EBITDA Margin | 3.09% | 3.37% |
| 7.79% | 8.94% | |
| Net Margin | 1.24% | 1.26% |
| 3.14% | 1.29% |
16 Analysts have issued a sales forecast Sinopharm Group 2026 . The average Sinopharm Group sales estimate is
This results in the following potential growth metrics:
17 Sinopharm Group Analysts have issued a net profit forecast 2026. The average Sinopharm Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 2.68 | 2.82 |
| 1.52% | 5.22% | |
| P/E | 5.29 | |
| EV/Sales | 0.15 |
17 Analysts have issued a Sinopharm Group forecast for earnings per share. The average Sinopharm Group EPS is
This results in the following potential growth metrics and future valuations:
Sinopharm Group...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
